Elevated serum levels of interleukin-10 and tumor necrosis factor are both associated with vital exhaustion in patients with cardiovascular risk factors

Psychosomatics

Volumn 51, Issue 3, 2010, Pages 248-256

  Meyer, Thomas ^b   Stanske, Beate ^b   Kochen, Michael M ^b   Cordes, Andreas ^b   Yüksel, Iraz ^b   Wachter, Rolf ^b   Lüers, Claus ^b   Scherer, Martin ^b   Binder, Lutz ^b   Pieske, Burkert ^a   Herrmann Lingen, Christoph ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CYTOKINE RELEASE; DEPRESSION; EARLY DIAGNOSIS; EXHAUSTION; FEMALE; HEART FAILURE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; PERSONALITY; PRIMARY MEDICAL CARE; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; VITAL EXHAUSTION; AGED; AUSTRIA; BLOOD; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; FATIGUE; GENETICS; IMMUNOLOGY; MIDDLE AGED; MORALITY; PERSONALITY TEST; PHYSIOLOGY; PRIMARY HEALTH CARE; PSYCHOLOGY; PSYCHOMETRY; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

AGED; AUSTRIA; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY DISEASE; FATIGUE; FEMALE; HEART FAILURE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; IRRITABLE MOOD; MALE; MIDDLE AGED; MORALE; PERSONALITY INVENTORY; PRIMARY HEALTH CARE; PSYCHOMETRICS; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953068178     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.51.3.248     Document Type: Article

References (39)

1. Appels A, Mulder P: Excess fatigue as a precursor of myocardial infarction. Eur Heart J 1988; 9:758-764
2. Prescott E, Holst C, Grønbæk M, et al: Vital exhaustion as a risk factor for ischaemic heart disease and all-cause mortality in a community sample: a prospective study of 4,084 men and 5,479 women in the Copenhagen City Heart Study. Int J Epidemiol 2003; 32:990-997
3. Appels A, Mulder P: Fatigue and heart disease: the association between "vital exhaustion" and past, present, and future coronary heart disease. J Psychosom Res 1989; 33:727-738
4. Schuitemaker GE, Dinant GJ, van der Pol GA, et al: Assessment of vital exhaustion and identification of subjects at increased risk of myocardial infarction in general practice. Psychosomatics 2004; 45:414-418
5. Cole SR, Kawachi I, Sesso HD, et al: Sense of exhaustion and coronary heart disease among college alumni. Am J Cardiol 1999; 84:1401-1405
6. Schuitemaker GE, Dinant GJ, van der Pol GA, et al: Vital exhaustion as a risk indicator for first stroke. Psychosomatics 2004; 45:114-118
7. Schwartz SW, Carlucci C, Chambless LE, et al: Synergism between smoking and vital exhaustion in the risk of ischemic stroke: evidence from The ARIC Study. Ann Epidemiol 2004; 14:416-424
8. Kop WJ, Appels AP, Mendes de Leon CF, et al: Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med 1994; 56:281-287
9. Tedgui A, Mallat Z: Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006; 86:515-531
10. Kwaijtaal M, van Diest R, Bär FW, et al: Inflammatory markers predict late cardiac events in patients who are exhausted after percutaneous coronary intervention. Atherosclerosis 2005; 182:341-348
11. Appels A, Bär FW, Bär J, et al: Inflammation, depressive symptomatology, and coronary artery disease. Psychosom Med 2000; 62:601-605
12. Janszky I, Lekander M, Blom M, et al: Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease. Brain Behav Immun 2005; 19:555-563
13. Wetzel D, Scheidt-Nave C, Rogausch A, et al: Medizinische versorgung in der praxis: eine Modellstudie zur Verbesserung der hausärztlichen Versorgungsforschung in Deutschland. Z Allgemeinmed 2003; 79:394-398
14. Himmel W, Hummers-Pradier E, Kochen MM, MedViP-Gruppe: Medizinische Versorgung in der hausärztlichen Praxis. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2006; 49:151-159
15. Wachter R, Lüers C, Kleta S, et al: Impact of diabetes on left-ventricular diastolic function in patients with arterial hypertension. Eur J Heart Failure 2007; 9:469-476
16. Gibbons WJ, Fruchter N, Sloan S, et al: Reference values for a multiple-repetition, 6-minute walk test in healthy adults older than 20 years. J Cardiopulm Rehabil 2001; 21:87-93
17. Camarri B, Eastwood PR, Cecins NM, et al: Six-minute walk distance in healthy subjects aged 55-75 years. Respir Med 2006; 100:658-665
18. Appels A, Höppener P, Mulder P: A questionnaire to assess premonitory symptoms of myocardial infarction. Int J Cardiol 1987; 17:15-24
19. Herrmann-Lingen C, Grande G, Jordan J, et al: Die Deutsche DS14: ein kurzes selbstbeurteilungsverfahren zur erfassung des prognoserelevanten "distressed personality type" (Typ D-persönlichkeit). Psychother Psychosom Med Psychol 2002; 52:92
20. Grande G, Jordan J, Kummel M, et al: Evaluation der Deutschen Typ-D-skala (DS14) und Prävalenz der Typ-D-persönlichkeit bei kardiologischen und psychosomatischen patienten sowie gesunden. Psychother Psychosom Med Psychol 2004; 54:413-422
21. Denollet J: DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med 2005; 67:89-97
22. Conraads VM, Denollet J, De Clerck LS, et al: Type D personality is associated with increased levels of tumour necrosis factor (TNF)-α and TNF-α receptors in chronic heart failure. Int J Cardiol 2006; 113:34-38
23. Denollet J, Pedersen SS, Vrints CJ, et al: Usefulness of Type D personality in predicting five-year cardiac events above and beyond concurrent symptoms of stress in patients with coronary heart disease. Am J Cardiol 2006; 97:970-973
24. Wirtz PH, von Känel R, Schnorpfeil P, et al: Reduced glucocorticoid sensitivity of monocyte interleukin-6 production in male industrial employees who are vitally exhausted. Psychosom Med 2003; 65:672-678
25. Harris TB, Ferrucci L, Tracy RP, et al: Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999; 106:506-512
26. Ridker PM, Rifai N, Stampfer MJ, et al: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101:1767-1772
27. Koukkunen H, Penttila K, Kemppainen A, et al: C-reactive protein, fibrinogen, interleukin-6, and tumour necrosis factor-α in the prognostic classification of unstable angina pectoris. Ann Med 2001; 33:37-47
28. Taylor A, Verhagen J, Blaser K, et al: Mechanisms of immune suppression by interleukin-10 and transforming growth factor-β: the role of T regulatory cells. Immunology 2006; 117:433-442
29. Uyemura K, Demer LL, Castle SC, et al: Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 1996; 97:2130-2138
30. Mallat Z, Heymes C, Ohan J, et al: Expression of interleukin-10 in human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arteroscler Thromb Vasc Biol 1999; 19:611-616
31. Kühn R, Löhler J, Rennick D, et al: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75:263-274
32. Brooks DG, Trifilo MJ, Edelmann KH, et al: Interleukin-10 determines viral clearance or persistence in-vivo. Nat Med 2006; 12:1301-1309
33. Ejrnaes M, Filippi CM, Martinic MM, et al: Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 2006; 203:2461-2472
34. Mege JL, Meghari S, Honstettre A, et al: The two faces of interleukin-10 in human infectious diseases. Lancet Infect Dis 2006; 6:557-569
35. Unden AL, Andreasson A, Elofsson S, et al: Inflammatory cytokines, behavior, and age as determinants of self-rated health in women. Clin Sci 2007; 112:363-373
36. Dantzer R, O'Connor JC, Freund GG, et al: From inflammation to sickness: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9:46-57
37. Pedersen SS, Middel B: Increased vital exhaustion among Type D patients with ischemic heart disease. J Psychosom Res 2001; 51:443-449
38. Pedersen SS, Daemen J, van de Sande M, et al: Type-D personality exerts a stable, adverse effect on vital exhaustion in PCI patients treated with paclitaxel-eluting stents. J Psychosom Res 2007; 62:447-453
39. Denollet J, Conraads VM, Brutsaert DL, et al: Cytokines and immune activation in systolic heart failure: the role of Type D personality. Brain Behav Immunol 2003; 17:304-309